Literature DB >> 1752778

Effects of hormones on tumor growth and immunoreactive insulin-like growth factor-1 of estrogen receptor-positive human breast cancer (MCF-7) transplanted in nude mice.

M Noguchi1, N Koyasaki, I Miyazaki, Y Mizukami.   

Abstract

The effects of estrogens and tamoxifen were analyzed on estrogen receptor-positive human breast cancer (MCF-7) transplanted into athymic nude mice. It was found that (1) the tumor growth and the proportion of 3H-thymidine-labeled cells were significantly increased in the 17 beta-estradiol dipropionate (E2) group, but significantly decreased in the tamoxifen (TAM) group with respect to the control group, and (2) the tumor content of insulin-like growth factor-1 (IGF-1) and the rate of IGF-1-positive cells were significantly lower in the E2 group, but significantly higher in the TAM group than in the control group. It was concluded that the tumor content of IGF-1 and the proportion of IGF-I-positive cells were inversely correlated to the tumor growth and the 3H-thymidine labeling index in vivo.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1752778      PMCID: PMC5918318          DOI: 10.1111/j.1349-7006.1991.tb01780.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  18 in total

1.  Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement.

Authors:  B Dawson-Hughes; D Stern; J Goldman; S Reichlin
Journal:  J Clin Endocrinol Metab       Date:  1986-08       Impact factor: 5.958

2.  Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture.

Authors:  R W Furlanetto; J N DiCarlo
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

3.  8th San Antonio Breast Cancer Symposium--Plenary lecture. Autocrine and paracrine growth regulation of human breast cancer.

Authors:  M E Lippman; R B Dickson; S Bates; C Knabbe; K Huff; S Swain; M McManaway; D Bronzert; A Kasid; E P Gelmann
Journal:  Breast Cancer Res Treat       Date:  1986       Impact factor: 4.872

4.  Partial characterization of insulin-like growth factor I in primary human lung cancers using immunohistochemical and receptor autoradiographic techniques.

Authors:  K Shigematsu; Y Kataoka; T Kamio; M Kurihara; M Niwa; H Tsuchiyama
Journal:  Cancer Res       Date:  1990-04-15       Impact factor: 12.701

5.  Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

Authors:  C L Arteaga; L J Kitten; E B Coronado; S Jacobs; F C Kull; D C Allred; C K Osborne
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  Altered cell cycle responses to insulin-like growth factor I, but not platelet-derived growth factor and epidermal growth factor, in senescing human fibroblasts.

Authors:  Y Y Chen; P S Rabinovitch
Journal:  J Cell Physiol       Date:  1990-07       Impact factor: 6.384

7.  Acute effects of growth hormone administration: vitamin A and visceral protein concentrations.

Authors:  S F Kemp; M E Canfield
Journal:  Acta Endocrinol (Copenh)       Date:  1983-12

8.  Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status.

Authors:  J C Schwander; C Hauri; J Zapf; E R Froesch
Journal:  Endocrinology       Date:  1983-07       Impact factor: 4.736

9.  Analysis of insulin-like growth factor I gene expression in malignancy: evidence for a paracrine role in human breast cancer.

Authors:  D Yee; S Paik; G S Lebovic; R R Marcus; R E Favoni; K J Cullen; M E Lippman; N Rosen
Journal:  Mol Endocrinol       Date:  1989-03

10.  Growth hormone and somatomedin C during post-menopausal replacement therapy with oestrogen alone and in combination with an antioestrogen.

Authors:  N Fröhlander; B von Schoultz
Journal:  Maturitas       Date:  1988-03       Impact factor: 4.342

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.